In the healthcare field today, perhaps no area holds as much promise and as many perils as weight control. Researchers see the same statistics that the rest of us do. They see the upcoming wave of obesity and diabetes diagnoses. They see the myriad complications that spring up from these conditions. And they want to address the problem in a simple way.
It's commonly believed that obese people run an especially high risk of developing type 2 diabetes because their extra weight leads to insulin resistance, or because some of their weight is the result of unhealthy diets.
The statements from august medical authorities were grand and sweeping. This was important news, they said. This would change everything. Pay attention, patients, they said. The experts have spoken, and their word should be taken as final.
It is commonly thought that Southerners are more overweight than their northern counterparts. Not so according to a study conducted at the University of Alabama at Birmingham (UAB) and published in the journal Obesity.
(Editor's Note: This article was orginally published in the April 2008 edition of Diabetes Health and later online as article 5658. We are reproducing the article in light of the American Medical Association's recent decision to treat obesity as a disease. That decision will spur much debate, and we think this article will help add some perspective to the discussion.)
Researchers at the Dana-Farber Cancer Institute in Boston report that they have discovered a naturally occurring hormone that can direct the body to burn more calories and increase its insulin sensitivity. Their results, based on lab experiments with mice, could potentially lead to therapies for diabetes, obesity, and even muscular dystrophy.
A 14-year study that tracked 4,434 obese type 2 patients shows that despite much talk about gastric bypass surgery as a "cure" for diabetes, a majority of the patients who underwent the procedure had no long-lasting remission of their symptoms.
According to a Scottish study recently published in Bioessays, the confusing signals created by modern technology's ability to turn night into day may be contributing to the global epidemic of obesity.
On a Sunday morning, a busy couple and their school-age children enter a superstore for their weekly grocery shopping. As they move through the center of the store, their shopping cart fills with packs of flavored yogurt, fruit sauces, fruit bars, fruit juices, flavored milk, prepared school lunches, snacks, and family meal packs.
New York researchers have reported that obese patients with type 1 diabetes who do not respond well to insulin may be able to improve their blood sugar control by adding liraglutide to their therapy. Liraglutide (brand name Victoza) is an injectible GLP-1 analog* that was introduced to the US market in 2010 to treat people with type 2 diabetes.
Statesville, NC - June, 26, 2012 - A staggering 78% of U.S. adults age 21+ report they have had one or more problems with their feet at some time in their lives, according to The National Foot Health Assessment 2012, a survey conducted for the Institute for Preventive Foot Health (IPFH) by The NPD Group. The most common foot maladies, plaguing both men and women, were ankle sprains (reported by roughly one in three respondents), followed by blisters, calluses, foot fatigue, cracked skin and athlete's foot.
Feeling tired? Your lack of rest may be putting you at increased risk of obesity and type 2 diabetes. That's the conclusion of a new paper, published in The American Journal of Human Biology, that looked at evidence collected from numerous experimental and observational studies. The link was clear: People who got less than six hours of sleep a night were more likely to have a high body mass index (BMI) and be obese. The connection found in the study seems stronger for children and teenagers, which is especially worrisome given the skyrocketing rates of type 2 diabetes in young people.
To discover the relationship between potassium levels and type 2 diabetes, a Johns Hopkins University study looked at more than 12,000 participants in the Atherosclerosis Risk in Communities Study (ARIC), performed in 1987 and 1996. The study found that as potassium levels went up, the incidence of diabetes among study participants went down. The more than 2,000 African Americans in the study had lower average potassium levels than the 9,000 Caucasians and were twice as likely to develop type 2 diabetes.
Up to seven years before she becomes pregnant, a woman's risk of developing diabetes during pregnancy can be identified based on routinely assessed measures of blood sugar and body weight, according to a Kaiser Permanente study published in the online issue of the American Journal of Obstetrics and Gynecology.
Due to the rising rates of diabetes and other chronic diseases related to obesity, children are expected to have a shorter lifespan than their parents for the first time in modern history. One in every three children aged two to 19 years is overweight or obese, and one-third of all children born in the year 2000 are expected to develop diabetes during their lifetime.
Just take a look around. It's pretty clear that many of us are carrying more weight than we used to. Obesity has skyrocketed in recent years, and it's not about to stop. Roughly one in three adults is obese today, and researchers now predict that 164 million adults will be obese by 2030. That's half of all adults in the country.
A new diabetes-friendly sugar, proven to help reduce sugar absorption, will soon be added to popular breads and cereals. "Sugir" is real sugar that contains an all-natural, tasteless additive called Emulin. Emulin, a patented formulation of compounds found in fruits, prevents the body from absorbing about a third of ingested sugar. A previous study showed that Emulin blocks the absorption of sugar by more than 30 percent.
A sleek new version of the humble blood pressure cuff is turning heads. The Withings Smart Blood Pressure Monitor just won a 2012 iF product design award for its maker, the French company Withings. The iF product design award is an international prize, sometimes called the "Design Oscar," that is awarded by a German group.
At 330 pounds, Kerry Watterson was tired of not being able to fit into his seat on an airplane. He had a family history of type 2 diabetes, and although doctors said his blood sugar was still at a normal level, he knew it was time to make a change. "I found out about the YDPP [YMCA Diabetes Prevention Program], called the director, and said, ‘I want to do this.' I'm so glad she took me," he says now, one year later.
The answer to the looming threat of obesity and cardiovascular disease could be as simple as putting one foot in front of the other. Indeed, according to a new campaign from managed-care giant Kaiser Permanente, walking has benefits in the short and long term.
Massachusetts-based Quantia Communications has released DailyCoachTM, a fitness coaching app that runs on both iOS and Android and is available free at https://dailycoach.quantiacare.com/. The app also runs on smart phones and tablets and is available on the Web.
An Australian researcher who deliberately fed his lab rats a high-sugar/high-fat diet says that a flavonoid called rutin helped block the growth of fat cells in their abdomens and kept them from putting on weight despite their bad diet. Flavonoids are plant pigments that researchers are finding have beneficial metabolic effects because of their antioxidant capabilities.
Here's news that has been receiving big play in U.S. and European media: British scientists have found that a gene called KLF14 acts as a "master switch" that controls other genes found in body fat-genes that are major factors in such conditions as type 2 diabetes, obesity, high cholesterol levels, and levels of glucose and insulin. The finding, by researchers at King's College London and Oxford University, could lead to treatments for diabetes, obesity, and related metabolic disorders by targeting the gene.
Canadian scientists have found that nobiletin, a substance found in high concentrations in tangerines, thwarted obesity and the onset of diabetes in lab mice. The researchers at the University of Western Ontario fed the mice a high-sugar, high-fat diet that mimicked the diet of many people in Western societies. One group of animals became obese, developing fatty livers and elevated levels of cholesterol and insulin-typical precursors to type 2 diabetes and cardiovascular disease. But a second group of mice, given the flavonoid nobiletin, did not develop the symptoms of the first group. The nobiletin prevented fatty buildup in the liver by blocking the genes that control the production of fat.
The National Institutes of Health has awarded a $1.15 million grant to a researcher at Eastern Virginia Medical School to investigate a protein that may prevent obese people from developing type 2 diabetes.
Greetings from Philadelphia International Airport! Airports are fascinating places...great for seeing what people look like and how they act under unusual circumstances. At this moment, I see a lot of truly overweight people. Most folks are treating the moving walkway like a ride at Disney World–just standing there, inching slowly along and staring blankly at the passing drywall. I don’t know…maybe the two sights are related. Have we really become this lazy? Have we “convenienced” our way out of being in shape? Have electronic toilet flushers, soap dispensers, and water faucets taken away our last opportunity to burn any calories at all?
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health.
Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.